LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. [electronic resource]
Producer: 20160321Description: 1015-26 p. digitalISSN:- 1178-2005
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Adult
- Aged
- Bronchodilator Agents -- administration & dosage
- Double-Blind Method
- Drug Combinations
- Female
- Fluticasone-Salmeterol Drug Combination -- administration & dosage
- Forced Expiratory Volume
- Glucocorticoids -- administration & dosage
- Glycopyrrolate -- administration & dosage
- Humans
- Indans -- administration & dosage
- Lung -- drug effects
- Male
- Middle Aged
- Muscarinic Antagonists -- administration & dosage
- Nebulizers and Vaporizers
- Pulmonary Disease, Chronic Obstructive -- diagnosis
- Quinolones -- administration & dosage
- Recovery of Function
- Severity of Illness Index
- Spirometry
- Surveys and Questionnaires
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.